Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer
Authors:
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 55 (3) , 679-687
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: A comparison of two fractionation schedulesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- In Vitro Studies of Taxol as a Radiation Sensitizer in Human Tumor CellsJNCI: Journal of the National Cancer Institute, 1994
- Investigation of taxol as a potential radiation sensitizerCancer, 1993
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Brief summary of radiobiological principles in fractionated radiotherapySeminars in Radiation Oncology, 1992
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Precision radiotherapy for cancer of the pancreas: Technique and resultsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1980